A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study

OBJECTIVES: To compare the efficacy and safety of innovator infliximab (INX) and CT-P13, an INX biosimilar, in active rheumatoid arthritis patients with inadequate response to methotrexate (MTX) treatment. METHODS: Phase III randomised, double-blind, multicentre, multinational, parallel-group study....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Yoo, Dae Hyun, Hrycaj, Pawel, Miranda, Pedro, Ramiterre, Edgar, Piotrowski, Mariusz, Shevchuk, Sergii, Kovalenko, Volodymyr, Prodanovic, Nenad, Abello-Banfi, Mauricio, Gutierrez-Ureña, Sergio, Morales-Olazabal, Luis, Tee, Michael, Jimenez, Renato, Zamani, Omid, Lee, Sang Joon, Kim, HoUng, Park, Won, Müller-Ladner, Ulf
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMJ Publishing Group 2013
Schlagworte:
Clinical and Epidemiological Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3786641/
https://ncbi.nlm.nih.gov/pubmed/23687260
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-203090
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge